Pharmacological topics of bone metabolism: A novel bisphosphonate for the treatment of periodontitis

Journal of Pharmacological Sciences

Volumn 106, Issue 4, 2008, Pages 555-558

  Shinoda, Hisashi ^a   Takeyama, Sadaaki ^a   Suzuki, Keiko ^b   Murakami, Shinobu ^a   Yamada, Shoji ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Bisphosphonate; Bone metabolism; Bone resorption; Dental calculus; Periodontitis; Prostaglandin E2

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CARBON; CYCLOOXYGENASE 2; DISODIUM DIHYDROGEN 4 [(METHYLTHIO)PHENYLTHIO]METHANEBISPHOSPHONATE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; TRK 530; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALVEOLAR BONE; ANTIINFLAMMATORY ACTIVITY; BONE METABOLISM; CONFERENCE PAPER; DRUG MECHANISM; ENZYME INHIBITION; INHIBITION KINETICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERIODONTITIS; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; TISSUE CULTURE; TOOTH CALCULUS;

EID: 42349113251     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FM0070272     Document Type: Conference Paper

References (16)

1. Fleisch H. Bisphosphonates in bone disease. 4th ed. San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo: Academic Press; 2000.
2. Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagen P. Structure-activity relationships of various bisphosphonates. Calcif Tissue Int. 1983;35:87-99.
3. Geddes AD, D'Souza SM, Ebetino FH, Ibotson KJ. Bisphosphonates: structure activity relationship and therapeutic implications. Bone Miner Res. 1994;8:265-306.
4. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Frith JC. Cellular and molecular mechanism of action of bisphosphonates. Cancer. 2000;88 Suppl:2961-2978.
5. Russell RGG. Determinants of structure-function relationships among bisphosphonates. Bone. 2007;40:S21-S25.
6. Tanahashi M, Funaba Y, Tateishi A, Kawabe N, Nakadate-Matsushita T. TRK-530 inhibits accumulation of superoxide anions derived from human polymorphonuclear leukocytes and bone-resorption induced by activated osteoclasts. Pharmacology. 1998;56:125-130.
7. Tanahashi M, Koike J, Kawabe N, Nakadate-Matsushita T. Inhibitory effect of TRK-530 on inflammatory cytokines in bone marrow of rats with adjuvant arthritis. Pharmacology. 1998;56:237-241.
8. Tanahashi M, Funaba Y, Itoh M, Kawabe N, Nakadate-Matsushita T. Inhibitory effects of TRK-530 on rat adjuvant arthritis. Pharmacology. 1998;56:242-251.
9. Suzuki K, Takeyama S, Kikuchi T, Yamada S, Sodek J, Shinoda H. Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analysed by laser scanning confocal microscopy. J Histochem Cytochem. 2005;53:1525-1537.
10. Suzuki K, Takeyama S, Sakai Y, Yamada S, Shinoda S. Current topics in pharmacological research on bone metabolism: Inhibitory effects of bisphosphonates on the differentiation and activity of osteoclasts. J Pharmacol Sci. 2006;100:189-194.
11. Brunsvold MA, Chaves ES, Komman KS, Aufdenorte TB, Wood R. Effects of bisphosphonates on experimental periodontitis in monkeys. J Periodontol. 1992;63:825-830.
12. Shoji K, Horiuchi H, Shinoda H. Inhibitory effects of a bisphosphonate (risedronate) on experimental periodontitis in rats. J Periodont Res. 1995;30:277-284.
13. Reddy MS, Weatherfold TW, Smith CA, West BD, Jeffcoat MK, Jacks TK. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol. 1995;66:211-217.
14. Mitsuta T, Horiuchi H, Shinoda H. Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis. J Periodontol. 2002;73:479-486.
15. Brinner WW, Francis MD, Widder JS. The control of dental calculus in experimental animals. Int Dent J. 1971;21:61-72.
16. Haq Sikder MN, Itoh M, Iwatsuki N, Shinoda H. Inhibitory effect of a novel bisphosphonate, TRK-530, on dental calculus formation in rats. J Periodontol. 2004;75:537-545.